tyb
China boots reporters at WSJ, NYT and Washington Post
Clash over media strains Sino-American relations in time of coronavirus. China has moved to disallow American journalists reporting for The Wall Street Journal, The New York Times and The Washington Post from working in the country, intensifying the two countries' conflict over media amid a trade war cool-down and a pandemic crisis. Reporters for the three publications, who are all U.S. citizens, have 10 days to hand over their press credentials, the Chinese Foreign Ministry announced Wednesday Beijing time.
China had already expelled three Wall Street Journal reporters last month, a day after Washington designated five Chinese state-owned media organizations – among them CGTV and China Daily – as government operatives and imposed personnel caps on their operations in the U.S. These moves show a growing strain in U.S.-China relations despite a temporary trade truce, pausing a tariff war thanks to a partial deal and negotiations suspended due to the new coronavirus outbreak.
The two governments' recent rhetoric around COVID-19 escalated matters further. Zhao Lijian, a Chinese Foreign Ministry official, last week claimed without evidence that the U.S. military brought the coronavirus to Wuhan.
U.S. President Donald Trump on Monday in a tweet called the coronavirus "the Chinese virus," later defending his word choice, saying, "I have to call it where it came from."
The Wall Street Journal previously angered China as well as the Chinese diaspora with an opinion piece titled, "China is the Real Sick Man of Asia." Apart from pulling credentials from journalists for the three publications – which are all blocked by state censorship – Beijing is also demanding their Chinese branches, as well as those of Voice of America and Time, submit filings about their staff, finance, operation and real estate. The foreign ministry in its latest statement characterized the moves as "countermeasures" against restrictions on Chinese media agencies operating in the U.S. and "growing discrimination and politically motivated oppression" against their journalists.
U.S. Secretary of State Mike Pompeo on Tuesday rejected the notion. "They suggested somehow that the actions that we had taken here in America prompted this. These aren't apples to apples," Pompeo said, when asked to comment on the issue after delivering remarks about the coronavirus situation.
"The individuals that we identified a few weeks back were not media that were acting here freely," he said. "They were part of Chinese propaganda outlets. We've identified these as foreign missions under American law."
https://asia.nikkei.com/Politics/China-boots-reporters-at-WSJ-NYT-and-Washington-Post
Adobe, Inc. EVP WW Operations sold:$11.25m-Mar 16
https://www.finviz.com/insidertrading.ashx?oc=1267573&tc=7&b=2
they are either being told to do it this way or are trying to hide it. Dorsey and Zuckerfag only claim $1 for a yearly salary
Development of coronavirus treatment advancing in Japan with existing meds
The development of methods to treat the new coronavirus disease is advancing in Japan, with researchers expected to see the results of clinical research using existing medication as early as the end of April. One medicine that experts in a government panel have expressed hope in is Ciclesonide (marketed as Alvesco), a type of steroid used in inhalers to treat asthma. A medical team including members of the Kanagawa Prefectural Ashigarakami Hospital administered this drug to three coronavirus disease patients. One of them, a woman in her 70s, saw her fever go down after two days, and her pneumonia symptoms also improved. She later tested negative for the virus and was discharged from hospital after eight days. The other two patients, a man in his 70s and a woman in her 60s, were able to be taken off respirators after receiving the medicine. Currently around 10 people are receiving it.
The National Institute of Infectious Diseases (NIID) reported that Ciclesonide was given to patients with the new coronavirus disease, COVID-19, after being found to have some effect in the treatment of Middle East Respiratory Syndrome (MERS), which is caused by another type of coronavirus. The drug is said to control inflammation and block multiplication of the virus. Also being tested is Remdesivir, which was developed as a treatment for the Ebola virus disease. As of March 16, it had been administered to nine patients. Japan's National Center for Global Health and Medicine is participating in international joint clinical trials with the United States and other countries to test the effectiveness of this medicine. Center official Norio Omagari said it had only been used in serious cases in which patients were on artificial respirators or heart-lung machines, but none of them had died.
Hydroxychloroquine (Plaquenil), which was developed to treat malaria, is a similar sort of medicine. When it was given to a male coronavirus disease patient in his 60s who was receiving dialysis treatment due to diabetes, his fever of over 38 degrees Celsius went down after three days, and his symptoms of pneumonia also improved. It is expected he can be released from hospital if he tests negative for the virus.
One more drug in focus is Favipiravir (Avigan), which is used to treat new types of influenza. Japan has a stockpile of about 2 million Avigan pills. Clinical research using the medication on novel coronavirus disease patients with mild to moderate symptoms began in March. The HIV treatment drug Lopinavir/ritonavir (Kaletra) is also being tested, having been administered to 54 patients as of March 1. It is hoped that both of these medications will be effective in preventing the virus from multiplying in patients' bodies. However, an individual related to Japan's Ministry of Health Labor and Welfare pointed out, "We've given Avigan to 70 to 80 people, but it doesn't seem to work that well when the virus has already multiplied. The same goes for Kaletra." Furthermore, care is said to be needed when women who could be pregnant or men who are trying to have children with their partners use Avigan, as it can subsequently cause deformities in fetuses.
https://mainichi.jp/english/articles/20200317/p2a/00m/0na/026000c
When JP Morgan execs sold a bunch of equity on April 15th last year that's when I thought this too. Sold it on the Titanic anniv. sinking. Like no one would notice that?
PAT024 USMC C-560 out of Portland Int'l and south
and every single anon is also self-taught in that regard.